CYB5R3

Chr 22AR

cytochrome b5 reductase 3

Also known as: B5R, DIA1

This gene encodes cytochrome b5 reductase, which includes a membrane-bound form in somatic cells (anchored in the endoplasmic reticulum, mitochondrial and other membranes) and a soluble form in erythrocytes. The membrane-bound form exists mainly on the cytoplasmic side of the endoplasmic reticulum and functions in desaturation and elongation of fatty acids, in cholesterol biosynthesis, and in drug metabolism. The erythrocyte form is located in a soluble fraction of circulating erythrocytes and is involved in methemoglobin reduction. The membrane-bound form has both membrane-binding and catalytic domains, while the soluble form has only the catalytic domain. Alternate splicing results in multiple transcript variants. Mutations in this gene cause methemoglobinemias. [provided by RefSeq, Jan 2010]

OMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.852 OMIM phenotypes
Clinical SummaryCYB5R3
🧬
Gene-Disease Validity (ClinGen)
methemoglobinemia due to deficiency of methemoglobin reductase · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
39 unique Pathogenic / Likely Pathogenic· 134 VUS of 323 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.85LOEUF
pLI 0.000
Z-score 2.03
OE 0.49 (0.290.85)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-0.42Z-score
OE missense 1.08 (0.971.21)
222 obs / 205.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.49 (0.290.85)
00.351.4
Missense OE?1.08 (0.971.21)
00.61.4
Synonymous OE?0.98
01.21.6
LoF obs/exp: 9 / 18.4Missense obs/exp: 222 / 205.1Syn Z: 0.12
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongCYB5R3-related methemoglobinemia due to deficiency of methemoglobin reductaseLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7228th %ile
GOF
0.75top 25%
LOF
0.2189th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

323 submitted variants in ClinVar

Classification Summary

Pathogenic24
Likely Pathogenic15
VUS134
Likely Benign78
Benign46
Conflicting13
24
Pathogenic
15
Likely Pathogenic
134
VUS
78
Likely Benign
46
Benign
13
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
11
10
3
0
24
Likely Pathogenic
3
11
1
0
15
VUS
3
125
6
0
134
Likely Benign
0
6
35
37
78
Benign
0
3
38
5
46
Conflicting
13
Total171558342310

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

32 pathogenic / likely-pathogenic (of 38) ClinVar copy-number / structural variants overlap CYB5R3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CYB5R3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →